Acamprosate Completed Phase 2 Trials for Alcohol Dependence / Alcohol-Related Disorders / Healthy Volunteers

IndicationsStatusPurposePhase
CompletedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT00106106Acamprosate to Reduce Symptoms of Alcohol Withdrawal
NCT00656630Medication Development in Alcoholism: Acamprosate Versus Naltrexone